A Study of Experimental NGM120 Combination Therapy for Advanced Solid Tumors and Pancreatic Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- NGM Biopharmaceuticals, Inc
- ID
- NCT04068896
- Phase
- Phase 1
- Study Type
- Interventional
- Last Updated